Short answer
Dyne Therapeutics, Inc. (DYN) filed an 8-K current report with the SEC on June 8, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders re-elected Lubner, Posner and Rhodes as Class III directors through the 2029 annual meeting.
Dyne Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders re-elected Lubner, Posner and Rhodes as Class III directors through the 2029 annual meeting
- Executive compensation approved with 147,732,142 votes for and 1,279,302 against
- Authorized common shares doubled from 200,000,000 to 400,000,000, increasing potential financing and dilution capacity
- Officer exculpation amendment approved and effective June 8, 2026
- Deloitte & Touche ratified as independent auditor for fiscal year ending December 31, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Dyne Therapeutics, Inc. 8-K filings
Get the next DYN 8-K as it lands
Follow DYN for push alerts, or ask the research agent what this filing means.